HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Surveillance may be ‘new normal’ for cancer survivors’ follow-up care
-
- FDA grants marketing approval to VALCHLOR gel for cutaneous T-cell lymphoma
- A 78-year-old woman presents with diplopia and ptosis Munir Ghesani, MD, FACNM; Mina Samir Erian Hanna, MD; Rahul Parikh, MD; Michael L. Grossbard, MD; Sagar Patel, MD
- Cooperative network helps generate high-level evidence to guide care of transplant recipients William Wood, MD
- Breast cancer survival poorer in black women
- L1CAM may predict outcomes in endometrial cancers
- Viscum album therapy safe, effective in pancreatic cancer
- PR, ER expression may predict outcomes in certain ovarian cancers
- Nearly 30% of non-Hispanic white high school girls tanned indoors
-
- Advanced colorectal neoplasia more likely in white men
- Antiretroviral therapy has not extended survival of patients with HIV-associated lymphoma
- Aspirin may heighten bleeding risk in AF patients on oral anticoagulants
- BEACOPP escalated may be new standard of care for advanced-stage Hodgkin’s lymphoma
- Beta-blocker use did not improve survival in patients with melanoma
- Bevacizumab plus chemotherapy extends survival in HER-2–negative breast cancer
- Bortezomib induction improved response, survival in myeloma
- CLABSIs more prevalent in cancer patients treated at home
-
- Despite new USPSTF recommendation, men remain favorably inclined to PSA testing
- Incidence of AIDS-defining cancers continues to decline
- Interventions needed to reduce global burden of sickle cell anemia
- Liver resection, radiofrequency ablation treated HCC in cirrhotic patients comparably
- Location of body fat may elevate CVD, cancer risk
- Long-term aspirin use may reduce colorectal cancer in women
- Low-grade prostate cancer did not develop aggressively over time
- Neoadjuvant intra-arterial cytoreductive chemotherapy may improve survival in patients with lacrimal gland adenoid cystic carcinoma
-
- Nodular melanomas identified by dermoscopic evaluation
- Patient supply, demand for pancreatic cancer clinical trials out of alignment
- Patients continued indoor tanning after BCC diagnoses
- Patients with SSPE appear to imitate those with segmental, proximal PE
- Pixantrone-based regimen associated with lower cardiotoxicity in patients with DLBCL
- Platelet reactivity after drug-eluting stent implantation predicted adverse outcomes
- Poor prognosis of infiltrative HCC improved with tumor-directed therapy
- Radiation therapy may not be factor in survival of MCC patients following surgery
-
- Screening tools effectively measured distress in melanoma patients
- Second-line chemotherapy effective in advanced gastric cancer
- Second-line chemotherapy superior to erlotinib for EGFR wild-type NSCLC
- SELECT: Omega-3 fatty acids increased prostate cancer risk
- Some major birth defects increased cancer risk in children
- Tax-PF superior to PF as induction therapy in HNSCC
- Voriconazole prophylaxis appeared to improve survival in pediatric AML
- Serum miR-21 may predict colorectal cancer diagnosis, prognosis
-
- Death rate from malignant melanoma 70% greater for men than women in UK
- Illinois joins five states in banning youths from indoor tanning
- Vical to stop development of Allovectin as melanoma treatment
- Grant will fund sarcoma research
- Professor named committee chair-elect
- Research foundation appoints new CEO
- Roswell Park, Lilly launch collaboration
- Seven scientists to receive ASH awards
-
- Society appoints first cancer control officer
- Age alone predicted survival in patients with brain metastasis
- 90% of women miscalculated their risk for breast cancer
- MRI did not improve outcomes for patients with DCIS
- Radiation therapy for DCIS did not increase risk for cardiovascular disease